Table 2 Overall pooled estimates of MBV infection in different subgroups
Subgroups | Prevalence [95% CIs] (%) | Number of studies analysed | Total number of subjects | Heterogeneity | Publication Bias, Egger’s test (p-value) | ||
|---|---|---|---|---|---|---|---|
I2 | p-value | ||||||
MBV in Human | |||||||
 Total | 22.5 [13.7; 31.4] | 31 | 34,367 | 100% | < 0.0001 | 0.0003 | |
Reported Virus | |||||||
 DENV | 32.4 [22.6; 42.1] | 19 | 24,133 | 100% | < 0.0001 | 0.0556 | |
 RVFV | 10.1 [ 0.0; 27.8] | 9 | 8053 | 100% | < 0.0001 | NA | |
 WNV | 6.4 [0.4; 12.3] | 2 | 2141 | 92% | < 0.01 | NA | |
 CHIKV | 2.4 [0.0; 6.4] | 2 | 2032 | 81% | 0.02 | NA | |
Country | |||||||
 Saudi Arabia | 22.3 [13.2; 31.3] | 28 | 30,307 | 100% | < 0.0001 | 0.0009 | |
 Qatar | 3.8 [3.2; 4.4] | 2 | 3810 | 0% | 0.34 | NA | |
 Oman | 67.7 [61.4; 73.4] | 1 | 250 | NA | NA | NA | |
MBV in Animal | |||||||
 Total | 11.6 [0.5; 22.7] | 13 | 19,062 | 99% | < 0.01 | 0.0137 | |
Reported Virus | |||||||
 RVFV | 1.5 [0.0; 3.7] | 8 | 18,018 | 90% | < 0.01 | NA | |
 WNV | 27.7 [3.8; 51.6] | 5 | 1044 | 100% | < 0.01 | NA | |
Country | |||||||
 Saudi Arabia | 12.6 [0.6; 24.5] | 12 | 18,802 | 99% | < 0.01 | NA | |
 Qatar | 0.0 [0.0; 1.4] | 1 | 260 | NA | NA | NA | |